Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma
- 1 August 2005
- journal article
- Published by Taylor & Francis in Hematology
- Vol. 10 (4) , 335-338
Abstract
Staging and monitoring of multiple myeloma (MM) is mainly based on monoclonal component quantification; the absence of such a parameter renders difficult follow up of patients with nonsecretory MM (nsMM). In this study our aims were to determine the specificity and sensitivity of Tc99m-sestaMIBI scintigraphy at diagnosis and during follow up of nsMM patients. Nine nsMM patients were prospectively studied at diagnosis and during treatment for a mean time of 33 months (range: 12-65+). Tc99m-sestaMIBI (MIBI) scintigraphy was compared to conventional imaging (CI: X ray with CAT or NMR details) at diagnosis and during follow up. At diagnosis, CI and MIBI were concordant in three patients; CI showed more focal lesions than MIBI in four patients, while MIBI revealed more focal lesions than CI in two patients. During the follow up, MIBI uptake was normal in the four patients who achieved remission. Five patients did not achieve remission: CI and MIBI were concordant in three, while MIBI was falsely negative in two patients. In conclusion, Tc99m-sestaMIBI scintigraphy has high sensitivity (no false positive cases) and 78% specificity (2/9 false negative cases) in tracing active nsMM lesions; it should be considered complementary to CI for monitoring this rare disease.Keywords
This publication has 11 references indexed in Scilit:
- Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell linesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- 99mTc-sestaMIBI Scintigraphy in Thalidomide-treated Refractory or Relapsed Multiple Myeloma PatientsLeukemia & Lymphoma, 2003
- Nonsecretory Multiple MyelomaSouthern Medical Journal, 2002
- Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantationAnnals of Hematology, 2001
- Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.European Journal of Nuclear Medicine and Molecular Imaging, 2001
- Bone marrow uptake of 99mTc-MIBI in patients with multiple myelomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Different patterns of technetium-99m sestamibi uptake in multiple myelomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- The use of 99mTc-MIBI scanning in multiple myelomaBritish Journal of Cancer, 1996
- Nonsecretory Multiple MyelomaActa Haematologica, 1985
- Comparison of bone scintigraphy and radiography in multiple myeloma.Radiology, 1980